Cannabinoids: Do they alleviate pain in cancer patients?
DOI:
https://doi.org/10.12775/JEHS.2025.80.57863Keywords
oncology, chronic pain, pain, endocannabinoid system cannaboidsAbstract
More than half of cancer patients experience chronic pain, especially those who have the disease in an advanced stage. Cancer is a complex illness that causes substantial morbidity and mortality. The mainstay of traditional pain care is opioids, which, although useful for some people, usually lead to insufficient pain relief and a host of negative side effects, such as opioid-refractory pain and reliance. A growing number of people are interested in alternative treatment choices, including cannabinoids made from the cannabis plant, as a result of these difficulties. This review centers on the endocannabinoid system (ECS), a sophisticated network of cell signals that is essential for controlling a number of physiological and pathological functions, including the feeling of pain. Major cannabinoids including Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are being investigated for their potential to lessen the negative effects of chemotherapy as well as their analgesic and anti-inflammatory qualities. The promising role of cannabis in cancer pain management is highlighted in this review, which also discusses the need for more study to determine their safety, effectiveness, and incorporation into clinical practice.
Methods
A review of the literature was conducted using the WHO and PubMed databases. Keywords: oncology, chronic pain, pain, endocannabinoid system and cannaboids. A total of 33 papers or websites were included in the review.
References
1. https://www.who.int/health-topics/cancer/guidelines-for-the-management-of-cancer-pain#tab=tab_1
2. https://www.who.int/publications/i/item/9789241550390
3. https://www.who.int/news-room/fact-sheets/detail/cancer
4. Carmine Secondulfo, Filomena Mazzeo, Grazia Maria Giovanna Pastorino, Antonella Vicidomini, Rosaria Meccariello, Francesca Felicia Operto. Opioid and Cannabinoid Systems in Pain: Emerging Molecular Mechanisms and Use in Clinical Practice, Health, and Fitness. doi: 10.3390/ijms25179407
5. Pavana P Bathula, M Bruce Maciver. Cannabinoids in Treating Chemotherapy-Induced Nausea and Vomiting, Cancer-Associated Pain, and Tumor Growth. doi: 10.3390/ijms25010074
6. Brigitte Cretu, Alexandra Zamfir, Sandica Bucurica, Andreea Elena Scheau, Ilinca Savulescu Fiedler, Constantin Caruntu, Ana Caruntu, Cristian Scheau. Role of Cannabinoids in Oral Cancer. doi: 10.3390/ijms25020969
7. Jess Hatfield, Krishna Suthar, Tricia A Meyer, Lucas Wong. The use of cannabinoids in palliating cancer-related symptoms: a narrative review. doi: 10.1080/08998280.2023.2301241
8. Di Cui, Yuanyuan Zhang, Mingyue Zhang. The effect of cannabinoid type 2 receptor agonist on morphine tolerance. doi: 10.1016/j.ibneur.2023.11.005
9. https://my.clevelandclinic.org/health/diseases/12194-cancer
10. Paweł Śledziński, Agnieszka Nowak-Terpiłowska, Joanna Zeyland. Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases. doi: 10.3390/ijms22010263
11. Siddharth A Szach, Anand Shyamla Gupta, Piyush Kumar. Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management. doi: 10.4103/jcrt.JCRT_488_18
12. Christopher A Legare, Wesley M Raup-Konsavage, Kent E Vrana. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals. doi: 10.1159/000521683
13. Zeinab Breijyeh, Buthaina Jubeh, Sabino A Bufo, Rafik Karaman, Laura Scrano. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses. doi: 10.3390/toxins13020117
15. Sonja Vučković, Dragana Srebro, Katarina Savić Vujović, Čedomir Vučetić, Milica Prostran. Cannabinoids and Pain: New Insights From Old Molecules. doi: 10.3389/fphar.2018.01259
16. Jason W Busse, Patrick Vankrunkelsven, Linan Zeng, Anja Fog Heen, Arnaud Merglen, Fiona Campbell, Lars-Petter Granan, Bert Aertgeerts, Rachelle Buchbinder, Matteo Coen 16, David Juurlink, Caroline Samer, Reed A C Siemieniuk, Nimisha Kumar, Lynn Cooper, John Brown, Lyubov Lytvyn, Dena Zeraatkar, Li Wang, Gordon H Guyatt, Per O Vandvik, Thomas Agoritsas. Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline. doi: 10.1136/bmj.n2040
18. Mia Hovgaard Jessen, Merete Petersen, Peter Derek Christian Leutscher. Cannabis medicine for chronic pain. DOI: 10.61409/V08230546
19. Krystyna Gowin, Meri Muminovic, Suzanna M Zick, Richard T Lee, Christina Lacchetti, Ashwin Mehta. Integrative Therapies in Cancer Care: An Update on the Guidelines. doi: 10.1200/EDBK_431554
20. Husam A ALSalamat, Sara Feras Abuarab, Hazem Mohamed Salamah, Anas Hasan Ishqair, Mohammad Fuad Dwikat, Anas Zakarya Nourelden, Aseel N Qandil, Yasmeen Barakat, Muna Barakat. Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer. doi: 10.1186/s42238-024-00233-z
21. Camren G Heider, Sasha A Itenberg, Jiajia Rao, Hang Ma, Xian Wu. Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review. doi: 10.3390/biology11060817
22. Paweł Śledziński, Joanna Zeyland, Ryszard Słomski, Agnieszka Nowak. The current state and future perspectives of cannabinoids in cancer biology. doi: 10.1002/cam4.1312
23. Mary A Hopkins, Brian E McGuire, David P Finn. Targeting the endocannabinoid system for the management of low back pain. doi: 10.1016/j.coph.2024.102438
24. Yutao Li, Amit Sharma, Michèle J Hoffmann, Dirk Skowasch, Markus Essler, Hans Weiher, Ingo G H Schmidt-Wolf. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells. doi: 10.3389/fimmu.2024.1268652
25. Manamele Dannies Mashabela, Abidemi Paul Kappo. Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective. doi: 10.3390/ijms25115659
26. Kelvin Le, Khang Duy Ricky Le, Johnny Nguyen, Jean Hua, Sarah Munday. The Role of Medicinal Cannabis as an Emerging Therapy for Opioid Use Disorder. doi: 10.1007/s40122-024-00599-1
27. Anna Stasiłowicz-Krzemień, Wiktoria Nogalska, Zofia Maszewska, Mateusz Maleszka, Maria Dobroń, Agnieszka Szary, Aleksandra Kępa, Marcin Żarowski, Katarzyna Hojan, Malgorzata Lukowicz, Judyta Cielecka-Piontek. The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders. doi: 10.3390/ijms25115749
28. Adriana Ribeiro, Rui Loureiro, Helena Cabral-Marques. Enhancing Cannabinoid Bioavailability in Pain Management: The Role of Cyclodextrins. doi: 10.3390/molecules29225340
29. James Troyer, Kimberson Tanco. Review of the Use of Medicinal Cannabis Products in Palliative Care. doi: 10.3390/cancers16071412
30. Ilana M. Braun, Kari Bohlke, Eric J. Roeland. Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline Q&A, https://doi.org/10.1200/OP.23.00775
31. Moniek Schouten, Sebastiaan Dalle, Dante Mantini, Katrien Koppo. Cannabidiol and brain function: current knowledge and future perspectives. doi: 10.3389/fphar.2023.1328885
32. Elly L Sjattar, Rosyidah Arafat, Lee Wan Ling. Cancer pain self-management interventions in adults: scoping review. doi: 10.1136/spcare-2024-004893
33. Yi-Ching Lee, Timothy Brake, Emma Zhao, Alix Dumitrescu, Wei Lee, Benjamin Tassie, Kok-Eng Khor, Andy Yi-Yang Wang. The use of interventional procedures for cancer pain. A brief review. doi: 10.1007/s00520-024-08467-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Magdalena Waśniowska, Magdalena Bujak, Wenancjusz Stołowski, Adrianna Czyżnikiewicz, Justyna Stadler-Szajda, Dominika Prystacka-Szar, Dagmara Neska, Jakub Siemko, Filip Grabowski, Natalia Rulewska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 110
Number of citations: 0
